Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome

Published:2020-04-06 Issue:4 Volume:13 Page:807-817
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Harrold John¹,Gisleskog Per Olsson²,Perez‐Ruixo Juan Jose¹,Delor Isabelle²,Chow Andrew¹,Jacqmin Philippe²,Melhem Murad¹

Affiliation:

1. Department of Clinical Pharmacology, Modeling and Simulation Amgen Inc. Thousand Oaks California USA

2. SGS Exprimo NV Mechelen Belgium

Funder

Amgen

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12777

Reference50 articles.

1. Are We Prepared for Nuclear Terrorism?

2. Acute radiation syndrome caused by accidental radiation exposure - therapeutic principles

3. US Food and Drug Administration.Product development under the animal rule: guidance for industry. Accessed March 15 2018.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2024

2. Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants;Advances in Therapy;2023-09-14

3. Delayed renal injury in survivors of hematologic acute radiation syndrome;International Journal of Radiation Biology;2023-01-25

4. Granulocyte Colony-Stimulating Factor (Neupogen®; Filgrastim) Accelerates Neutrophil Recovery in a Rodent Model of Sulfur Mustard-Induced Hematologic Toxicity;Disaster Medicine and Public Health Preparedness;2023

5. Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments;Archives of Pharmacal Research;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3